‘Translators’ Will Form The Next Generation Of Biopharma Leaders
Interview With 2020 Rising Leader Rabia Khan
Executive Summary
Rabia Khan, managing director of discovery sciences at Sensyne Health, talks to In Vivo about pairing biology with technology in the most effective way, managing COVID-19 challenges and what the future leaders of biopharma might look like.
You may also be interested in...
VC View: Deal-Making During A Pandemic And 2021 Expectations
In the latest instalment of VC Playbook, In Vivo gets to know Arix Bioscience, a relatively young venture capital firm that went public in 2016. Arix has “has many similarities yet some key differences from a typical venture capital firm,” says the management team.
Snapshot: August Highlights
A selection of articles you might have missed from August 2020, including exclusive interviews with industry leaders and a review of financing trends.
How Has COVID-19 Influenced Investment Trends?
Health care funding in the first half of 2020 reached $10.4bn, according to a mid-year report from Silicon Valley Bank, nearly matching 2019’s full-year record. As well as the COVID-19 pandemic though, other global events, such as the US election, could become distractions in the second half of the year.
Need a specific report? 1000+ reports available
Buy Reports